Search results for "Clero"

showing 10 items of 2052 documents

An Intercellular Flow of Glutathione Regulated by Interleukin 6 Links Astrocytes and the Liver in the Pathophysiology of Amyotrophic Lateral Sclerosis

2021

Oxidative stress has been proposed as a major mechanism of damage to motor neurons associated with the progression of amyotrophic lateral sclerosis (ALS). Astrocytes are the most numerous glial cells in the central nervous system and, under physiological conditions, protect neurons from oxidative damage. However, it is uncertain how their reactive phenotype may affect motor neurons during ALS progression. In two different ALS mouse models (SOD1G93A and FUS-R521C), we found that increased levels of proinflammatory interleukin 6 facilitate glutathione (GSH) release from the liver to blood circulation, which can reach the astrocytes and be channeled towards motor neurons as a mechanism of anti…

amyotrophic lateral sclerosisPhysiologySistema nerviós central MalaltiesClinical BiochemistryastrocytesEsclerosi múltipleNeuronesCell BiologyRM1-950liverBiochemistryamyotrophic lateral sclerosis; liver; astrocytes; motor neurons; mitochondria; glutathione; oxidative stressArticlemitochondriaoxidative stressmotor neuronsTherapeutics. PharmacologyglutathioneMolecular Biology
researchProduct

Reduced brain N-acetyl-aspartate in frontal lobes suggests neuronal loss in patients with amyotrophic lateral sclerosis

1996

International audience; Abstract: We performed proton magnetic resonance spectroscopy (IH-MRS) in three patients with amyotrophic lateral sclerosis (ALS) to evaluate the distribution and extent of cortical neuronal damage as demonstrated by decreased N-acetyl-aspartate (NAA) levels. We examined primary motor (precentral gyrus) and parietal neocortical (superior parietal gyrus) regions. ALS was defined with lower and upper motor neuron signs. Compared with matched healthy controls, ALS patients had a significant decrease in NAA levels in the primary motor cortex (p<0.001) compared with parietal regions and homologous regions in healthy controls. Two clinical applications can be extracted: fi…

amyotrophic lateral sclerosis[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingnervous system[INFO.INFO-IM]Computer Science [cs]/Medical Imaging[INFO.INFO-IM] Computer Science [cs]/Medical ImagingN-acetyl-aspartateneuron
researchProduct

Unraveling Moral Reasoning in Amyotrophic Lateral Sclerosis: How Emotional Detachment Modifies Moral Judgment

2020

In the last decade, scientific literature provided solid evidence of cognitive deficits in amyotrophic lateral sclerosis (ALS) patients and their effects on end-life choices. However, moral cognition and judgment are still poorly investigated in this population. Here we aimed at evaluating both socio-cognitive and socio-affective components of moral reasoning in a sample of 28 ALS patients. Patients underwent clinical and neuropsychological evaluation including basic cognitive and social cognition measures. Additionally, we administered an experimental task including moral dilemmas, with instrumental and incidental conditions. Patients' performances were compared with a control group [healt…

amyotrophic lateral sclerosisamyotrophic lateral sclerosis emotion detachment moral cognition moral judgment social cognitionPopulationlcsh:BF1-990Moral reasoningsocial cognitionMoral cognitionemotion detachmentSocial cognitionmedicinePsychologyAmyotrophic lateral sclerosiseducationGeneral Psychologyeducation.field_of_studyNeuropsychologyCognitionBrief Research Reportmedicine.diseaseEmotional detachmentmoral judgmenthumanitieslcsh:Psychologymedicine.symptommoral cognitionPsychologyClinical psychologyFrontiers in Psychology
researchProduct

How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease

2022

r Abstract: Even if amyotrophic lateral sclerosis is still considered an orphan disease to date, its prevalence among the population is growing fast. Despite the efforts made by researchers and pharmaceutical companies, the cryptic information related to the biological and physiological onset mechanisms, as well as the complexity in identifying specific pharmacological targets, make it almost impossible to find effective treatments. Furthermore, because of complex ethical and economic aspects, it is usually hard to find all the necessary resources when searching for drugs for new orphan diseases. In this context, computational methods, based either on receptors or ligands, share the capabil…

amyotrophic lateral sclerosisamyotrophic lateral sclerosis; orphan diseases; molecular topology; drug design; QSAR; drug repurposingdrug repurposingdrug designQSARRPharmaceutical ScienceArticlemolecular topologyRS1-441orphan diseasesPharmacy and materia medicaDrug DiscoveryMolecular MedicineMedicinePharmaceuticals; Volume 15; Issue 1; Pages: 94
researchProduct

NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis

2021

Charcot first described amyotrophic lateral sclerosis (ALS) between 1865 and 1874 as a sporadic adult disease resulting from the idiopathic progressive degeneration of the motor neuronal system, resulting in rapid, progressive, and generalized muscle weakness and atrophy. There is no cure for ALS and no proven therapy to prevent it or reverse its course. There are two drugs specifically approved for the treatment of ALS, riluzol and edaravone, and many others have already been tested or are following clinical trials. However, at the present moment, we still cannot glimpse a true breakthrough in the treatment of this devastating disease. Nevertheless, our understanding of the pathophysiology…

amyotrophic lateral sclerosisbusiness.industryQH301-705.5NAD<sup>+</sup>Medicine (miscellaneous)Degeneration (medical)Diseasemedicine.disease_causemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyPathophysiologychemistry.chemical_compoundAtrophyantioxidantschemistryEdaravoneMedicinemotor neuronsoxidative stressNAD+ kinaseAmyotrophic lateral sclerosisBiology (General)businessNeuroscienceOxidative stressBiomedicines
researchProduct

Case Report: Association of a Variant of Unknown Significance in the FIG4 Gene With Frontotemporal Dementia and Slowly Progressing Motoneuron Disease…

2020

BackgroundModern genetics have in many ways revolutionized clinical routine and have, for instance, shown that formerly distinct disease entities relate to common pathogenic mutations. One such example is the connection between dementia and amyotrophic lateral sclerosis (ALS) in a continuous disease spectrum affirmed by the discovery of shared mutations.Case ReportWe describe a new variant in the FIG4 gene in a patient with slowly progressing frontotemporal dementia (FTD) and probable primary lateral sclerosis (PLS). The patient initially showed depressive symptoms and global cognitive deficits. Severe difficulties with language and hallucinations became clearer as the disease progressed. N…

amyotrophic lateral sclerosisneurodegenerationgeneticsFIG4lcsh:Neurosciences. Biological psychiatry. Neuropsychiatrydementialcsh:RC321-571Frontiers in Neuroscience
researchProduct

A Deletion of the Nuclear Localization Signal Domain in the Fus Protein Induces Stable Post-stress Cytoplasmic Inclusions in SH-SY5Y Cells

2021

Mutations in Fused-in-Sarcoma (FUS) gene involving the nuclear localization signal (NLS) domain lead to juvenile-onset Amyotrophic Lateral Sclerosis (ALS). The mutant protein mislocalizes to the cytoplasm, incorporating it into Stress Granules (SG). Whether SGs are the first step to the formation of stable FUS-containing aggregates is still unclear. In this work, we used acute and chronic stress paradigms to study the SG dynamics in a human SH-SY5Y neuroblastoma cell line carrying a deletion of the NLS domain of the FUS protein (homozygous: ΔNLS–/–; heterozygous: ΔNLS+/–). Wild-type (WT) cells served as controls. We evaluated the subcellular localization of the mutant protein through immuno…

amyotrophic lateral sclerosisstomatognathic systemGeneral Neurosciencecytoplasmic inclusionsNeurosciences. Biological psychiatry. NeuropsychiatrySettore MED/26 - Neurologianuclear localization signal (NLS)stress granules (SG)Fused-in-Sarcoma proteinRC321-571NeuroscienceOriginal Research
researchProduct

Hsp60 in Inflammatory Disorders

2019

Heat shock proteins (HSP) including HSP60 are immunogenic proteins shared by particular microbial agents and mammals. HSP60 has been implicated in multiple inflammatory disorders and autoimmune diseases mostly through its interactions with the immune system. Such diseases include inflammatory bowel disease, chronic obstructive pulmonary disease, Hashimoto’s thyroiditis, myasthenia gravis, multiple sclerosis and even atherosclerosis plaques among others. It is present in the cytosol, cell membrane, cell surface as well as in the extracellular space and in the circulation. As a super antigen, HSP60 has the dual role as an immunomodulator and as a biomarker, a node molecule in balance between …

animal structuresbusiness.industryMultiple sclerosisfungichemical and pharmacologic phenomenaDiseasemedicine.diseasemedicine.disease_causecomplex mixturesInflammatory bowel diseaseAutoimmunityBiomarkerImmune systemHeat shock proteinImmunologymedicineHSP60business
researchProduct

Bioactive effects of citrus flavonoids and role in the prevention of atherosclerosis and cancer

2022

Citrus fruits are the main fruits of the Mediterranean diet and have been long recognized for their beneficial effects on human health. Observational studies have shown a significant association between dietary flavonoid intake and reduced risk of cardiovascular and malignant diseases. The beneficial effects of citrus fruits on human health appear to be due to their high content in vitamins, minerals and fibers. In particular, the antioxidant and anti-inflammatory activities have been indicated as some of the mechanisms through which citrus fruits may thwart the development of chronic degenerative diseases such as atherosclerosis and cancer. This review would critically examine the results …

antioxidantQH301-705.5Biochemistry (medical)food and beveragesPlant Sciencehuman healthantioxidant activitieGeneral Biochemistry Genetics and Molecular Biologycardiovascular diseasesatherosclerosicardiovascular diseaseCitrus flavonoidsantiinflammatory activitiescanceratherosclerosisBiology (General)Citrus flavonoidSettore MED/49 - Scienze Tecniche Dietetiche Applicate
researchProduct

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

2022

Abstract MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for MOG antibodies is unavailable or shows uncertain results. We aimed to identify MRI and clinical markers that differentiate non-acute MOG-antibody disease from aquaporin 4 (AQP4)-antibody neuromyelitis optica spectrum disorder and relapsing remitting multiple sclerosis, guiding in the identification of patients with MOG-antibody disease in clinical practice. In this cross-sectional retrospective study, data from 16 MAGNIMS centres were i…

aquaporin 4-antibody positive neuromyelitis optica spectrum disorder; differential diagnosis; imaging; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody-associated diseaseaquaporin 4-antibody positive neuromyelitis optica spectrum disordermyelin oligodendrocyte glycoprotein antibody-associated diseasedifferential diagnosisimagingNeurology (clinical)multiple sclerosis
researchProduct